Maternal adiponectin and visfatin concentrations in normal and complicated pregnancies

Clinical and Experimental Obstetrics and Gynecology

Volumn 40, Issue 2, 2013, Pages 261-267

  Cetinkaya Demir, B ^a   Atalay, M A ^a   Ozerkan, K ^a   Doster, Y ^a   Ocakoglu, G ^a   Kucukkomurcu, S ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Adiponectin; Preeclampsia; Pregnancy; SGA fetuses; Visfatin

Indexed keywords

ADIPONECTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY COMPLICATION; PROSPECTIVE STUDY; THIRD TRIMESTER PREGNANCY;

ADIPONECTIN; ADULT; APGAR SCORE; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES;

EID: 84879588934     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Wolf M., Sandler L., Munoz K., Hsu K., Ecker J.L., Thadhani R.: "First Trimester insulin resistance and subsequent preeclampsia: a prospective study". J. Clin. Endocrinol. Metab., 2002, 87, 1563.
2. Seely E.W., Solomon C.G.: "Insulin resistance and its potential role in pregnancy-induced hypertension". J. Clin. Endocrinol. Metab., 2003, 88, 2393.
3. Roberts J.M., Gammill H.S.: "Preeclampsia: recent insights". Hypertension, 2005, 46, 1243.
4. Sibai B., Dekker G., Kupferminc M.: "Pre-eclampsia". Lancet, 2005, 365, 785.
5. Solomon C.G., Seely E.W.: "Brief review: hypertension in pregnancy: a manifestation of the insulin resistance syndrome?". Hypertension, 2001, 37, 232.
6. Briana D.D., Malamitsi-Puchner A.: "Adipocytokines in normal and complicated pregnancies". Reproductive Sciences, 2009, 921.
7. Chen J., Tan B., Karteris E., Zervou S., Digby J., Hillhause G.W. et al.: "Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines". Diabetologia, 2006, 49, 1292.
8. Wiecek A., Adamczak M., Chudek J.: "Adiponectin an adipokine with unique metabolic properties". Nephrol. Dial. Transplant., 2007, 22, 981.
9. Catalano P.M., Hoegh M., Minium J., Huston-Presley W., Bernard S., Kalhan S. et al.: "Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism". Diabetologia, 2006, 49, 1677.
10. Mazaki-Tovi S., Kanety H., Pariente C., Hemi R., Wiser A., Schiff E. et al.: "Maternal serum adiponectin levels during human pregnancy". J. Perinatol., 2007, 27, 77.
11. Cortelazzi D., Corbetta S., Ronzoni S., Pelle F., Marconi A., Cozzi V. et al.: "Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies". Clin. Endocrinol. (Oxf)., 2007, 66, 447.
12. Ouyang Y., Chen H., Chen H.: "Reduced plasma adiponectin and elevated leptin in pre-eclampsia". Int. J. Gynaecol. Obstet., 2007, 98, 110.
13. Haugen F., Ranheim T., Harsem N.K., Lips E., Staff A.C., Drevon C.A.: "Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression". Am. J. Physiol. Endocrinol. Melab., 2006, 290, 326.
14. Hendler I., Blackwell S.C., Mehta S.H., Whitty J.E., Russell E., Sorokin Y. et al.: "The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia". Am. J. Obstet. Gynecol., 2005, 193, 979.
15. Kajantie E., Kaaja R., Ylikorkala O., Andersson S., Lavuori H.: "Adiponectin concentrations in maternal serum: elevated in preeclampsia but unrelated to insulin sensitivity". J. Soc. Gynecol. Investig., 2005, 12, 433.
16. Ramsay J.E., Jamieson N., Greer I.A., Sattar N.: "Paradoxical elevation in adiponectin concentrations in women with preeclampsia". Hypertension, 2003, 42, 891.
17. Odden N., Henriksen T., Holter E., Grete Skar A., Tjade T., Morkrid L.: "Serum adiponectin concentration prior to clinical onset of preeclampsia". Hypertens. Pregnancy, 2006, 25, 129.
18. Chen M.P., Chung F.M., Chang D.M., Jack C.-R. Tsai, Han-Fen Huang, Shyi-Jang Shin: "Elevated plasma level of visfatin/Pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus". J. Clin. Endocrinol. Metab., 2006, 91, 295.
19. Takebayashi K., Suetsugu M., Wakabayashi S., Aso Y., Inukai T.: "Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus". Metabolism, 2007, 56, 451.
20. Kryzanowska K., Krugluger W., Mittermayer F., Rahman R., Haider D., Shnawa N.: "Increased visfatin concentrations in women with gestational diabetes mellitus". Clin. Sci., 2006, 110, 605.
21. Chan T.F., Chen Y.L., Lee C.H., Chou F.H., Wu L.C., Jong S.B.: "Decreased plasma visfatin concentrations in women with gestational diabetes mellitus". J. Soc. Gynecol. Investig., 2006, 13, 364.
22. Dogru T, Sonmez A., Tasci I., Bozoglu E., Yilmaz M.I., Genc H.: "Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance". Diabetes Res. Clin. Pract., 2007, 76, 24.
23. Fasshauer M., Waldeyer T., Seeger J., Schrey S., Ebert T., Kratzsch J. et al.: "Serum levels of the adipokine visfatin are increased in pre-eclampsia". Clin. Endocrinol., 2008, 69, 69.
24. Zulfikaroglu E., Isman F., Payasli A., Kilic S., Kucur M., Danisman N.: "Plasma visfatin levels in preeclamptic and normal pregnancies". Arch. Gynecol. Obstet., 2010, 281, 995.
25. Hu W., Wang Z., Wang H., Huang H., Dong M.: "Serum visfatin levels in late pregnancy and pre-eclampsia". Acta Obstet. Gynecol. Scand., 2008, 87, 413.
26. Kyriakakou M., Malamitsi-Puchner A., Militsi H.: "Leptin and adiponectin concentrations in intrauterine growth restricted and appropriate for gestational age fetuses, neonates and their mothers". Eur. J. Endocrinol., 2008, 158, 343.
27. Fasshauer M., Bluher M., Stumvoll M., Tonessen P., Faber R., Stepan H.: "Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function". Clin. Endocrinol., 2007, 66, 434.
28. Mazaki-Tovi S., Romero R., Kim S.K., Vaisbuch E., Kusanovic J.P., Erez O.: "Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?". J. Mat.-Fet. Neonatal Med., 2010, 23, 857.
29. Malamitsi-Puchner A., Briana D.D., Boutsikou M., Kouskouni E., Hassiakos D., Gourgiotis D.: "Perinatal circulating visfatin levels in intrauterine growth restriction". Pediatrics, 2007, 119, 1314.
30. Seeds J.W.: "Impaired fetal growth: definition and clinical diagnosis". Obstet. Gynecol., 1984, 64, 303.
31. Nyberg D.A., Abuhamad A., Ville Y.: "Ultrasound assessment of abnormal fetal growth". Sem. Perinat., 2004, 28, 3.
32. Arduini D., Rizzo G.: "Normal values of pulsatility index from fetal vessels: a cross-sectional study on 1556 healthy fetuses". J. Perinat. Med., 1990, 18, 165.
33. Ming F., Zhou R., Cheng W.B., Tie W.W.: "Study of adiponectin expression in placenta and its correlation with preeclampsia". Zhonghua Fu Chan Ke Za Zhi. 2008, 43, 90.
34. Trujillo M.E., Scherer P.E.: "Adiponectin; journey from an adipocyte secretory protein to biomarker of the metabolic syndrome". J. Intern. Med., 2005, 257, 167.
35. Pajvani U.B., Hawkins M., Combs T.P., Rajala M.W., Doebber T., Berger J.P.: "Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity". J. Biol. Chem., 2004, 279, 12152.
36. Mazaki-Tovi S., Romero R., Kusanovic J.P., Erez O., Vaisbuch E., Gotsch F.: "Adiponectin multimers in maternal plasma". J. Maternal-Fetal Neonat. Med., 2008, 21, 796.
37. Mazaki-Tovi S., Kanety H., Pariente C.: "Cord blood adiponectin in large-for-gestational-age newborns". Am. J. Obstet. Gynecol., 2005, 193, 1238.
38. Chan T.F., Yuan S.S.F., Chen H.S., Guu C.F., Wu L.C., Yeh Y.T.: "Correlations between umbilical and maternal serum adiponectin - levels and neonatal birthweights". Acta Obstet. Gynecol. Scand., 2004, 83, 165.
39. Kotani Y., Yokota I., Kitamura S.: "Plasma adiponectin levels in newborns are higher than those in adults and positively correlated with birth weight". Clin. Endocrinol., 2004, 61, 418.
40. Lindsay R.S., Walker J.D., Havel P.J.: "Adiponectin ispresent incordbloodbut isunrelatedtobirthweight". Diab. Care., 2003 26, 2244.
41. Morgan S.A., Bringolf J.B., Seidel E.R.: "Visfatin expression is elevated in normal human pregnancy". Peptides., 2008, 29, 1382.
42. Telejko B., Kuzmicki M., Zonenberg A., Szmatowicz J., Wawrusiewicz-Kurylonek N., Nikolajuk A. et al.: "Visfatin in gestational diabetes: Serum level and mRNA expression in fat and placental tissue". Diab. Res. Clin. Pract., 2009, 84, 68.
43. Kralisch S., Klein J., Lossner U., Bluher M., Paschke R., Stumvoll M. et al.: "Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes". Am. J. Physiol. Endocrinol. Metabol., 2005, 289, 586.
44. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K.: "Visfatin: a protein secreted by visceral fat that mimics the effects of insulin". Science, 2005, 307, 426.